Cases of RSV and flu are ticking up among young children in the U.S. even as overall respiratory virus activity remains low, ...

Valneva reports long-lasting antibody persistence in its chikungunya vaccine three years post-dose, supporting its global ...

Travel Health Pro, a platform run by the UK Health Security, has issued an advisory to travelers to reduce the spread of ...

The deadly Marburg virus disease, similar to Ebola and is now being referred to as the Bleeding Eye Virus, is spreading ...

Respiratory syncytial virus (RSV) is an infectious respiratory disease that can look and sound a lot like a cold, with ...

REUTERS /AMANDA PEROBELL / 2023 An employee dilutes poultry serum samples for ELISA test for the detection of antibodies to the avian influenza virus at the Reference Laboratory of the World ...

Antibody levels remained high at 96% seroresponse in line with the two-year persistence data This long-lasting antibody persistence was ...

Beyfortus, a long-acting RSV antibody treatment for infants, will launch in Korea next month, aiming to address rising ...

The H5N1 bird flu outbreak in the U.S. has so far been shockingly mild. Researchers have some theories as to why.

Researchers at Kumamoto University have discovered a monoclonal antibody capable of neutralizing a wide range of SARS-CoV-2 ...

A recently approved immunization drug is helping to limit the severity of a respiratory disease that afflicts young children ...

Heading into the fifth U.S. winter of COVID-19, an Emory University lab has found the presence – or absence – of a particular ...